Suzanne Kyle
- Oncology top 0.5%
- PARP inhibition in cancer therapy 19
- Molecular Biology top 1%
- DNA Repair Mechanisms 16
- Cancer therapeutics and mechanisms 6
- CRISPR and Genetic Engineering 2
- Reproductive Medicine top 2%
- Cancer Research top 5%
- Genetics top 2%
- BRCA gene mutations in cancer 3
-
- Toxin Mechanisms and Immunotoxins 3
-
- Integrated Circuits and Semiconductor Failure Analysis 2
-
- Chemotherapy-induced cardiotoxicity and mitigation 2
- Co-authors
- Nicola J. CurtinHuw D. ThomasThomas HelledayMark MeuthNiklas SchultzHelen E. BryantElena López‐KnowlesZdeněk Hostomský
- Journals
- Clinical Cancer Research (4 papers)British Journal of Cancer (4 papers)Molecular Cancer Therapeutics (3 papers)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Suzanne Kyle
23 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 4.2k
- Molecular Biology 4.2k
- Reproductive Medicine 446
- Cancer Research 622
- Genetics 804
Countries citing papers authored by Suzanne Kyle
This map shows the geographic impact of Suzanne Kyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Kyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Kyle more than expected).
Fields of papers citing papers by Suzanne Kyle
This network shows the impact of papers produced by Suzanne Kyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Kyle. The network helps show where Suzanne Kyle may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Suzanne Kyle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 15 | |
| 2 | 2014 | 33 | |
| 3 | 2013 | 113 | |
| 4 | 2012 | 60 | |
| 5 | 2011 | 43 | |
| 6 | 2011 | 152 | |
| 7 | 2010 | 207 | |
| 8 | 2010 | 80 | |
| 9 | 2010 | 191 | |
| 10 | 2009 | 42 | |
| 11 | 2008 | 30 | |
| 12 | 2007 | 233 | |
| 13 | Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerasebreakdown → | 2005 | 3780 |
| 14 | 2004 | 60 | |
| 15 | 2004 | 33 | |
| 16 | Design and evaluation of novel potent inhibitors of poly (ADP-ribose) polymerase | 2000 | 1 |
| 17 | 2000 | 27 | |
| 18 | Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines. | 2000 | 164 |
| 19 | 1997 | 19 | |
| 20 | 1996 | 109 |
About Suzanne Kyle
Suzanne Kyle is a scholar working on Oncology, Molecular Biology and Physiology, having authored 23 papers that have together received 5.6k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (19 papers), DNA Repair Mechanisms (16 papers), Cancer therapeutics and mechanisms (6 papers), BRCA gene mutations in cancer (3 papers), Toxin Mechanisms and Immunotoxins (3 papers), CRISPR and Genetic Engineering (2 papers), Integrated Circuits and Semiconductor Failure Analysis (2 papers) and Chemotherapy-induced cardiotoxicity and mitigation (2 papers). The work is most often cited by research in Oncology (4.2k citations), Molecular Biology (4.2k citations) and Reproductive Medicine (446 citations). Suzanne Kyle has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Nicola J. Curtin, Huw D. Thomas, Thomas Helleday, Mark Meuth, Niklas Schultz, Helen E. Bryant, Elena López‐Knowles, Zdeněk Hostomský, David R. Newell and Barbara W. Durkacz. Their work appears in journals such as Clinical Cancer Research, British Journal of Cancer, Molecular Cancer Therapeutics, Nature and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.